← Browse by Condition
Medical Condition
clinical stage iii hpv mediated p16 positive oropharyngeal carcinoma ajcc v8
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT05172245 Phase 1
Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Enrollment
46 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
NCT05541016 Phase 2
Recruiting
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Enrollment
455 pts
Location
United States
Sponsor
Mayo Clinic